글로벌 구획 증후군 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 구획 증후군 치료 시장

글로벌 구획 증후군 치료 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 위에 언급된 연구 예측 기간 동안 4.20%의 건강한 CAGR로 성장하고 있다고 분석합니다.

구획 증후군은 신체의 폐쇄된 근육 공간 내부에 과도한 압력이 축적될 때 발생합니다 . 이러한 유형의 증후군은 일반적으로 부상 후 출혈이나 부기로 인해 발생합니다. 구획 증후군은 영향을 받는 조직으로의 혈류를 방해합니다. 영구적인 부상을 방지하기 위해 수술이 필요한 응급 상황이 될 수 있습니다. 특정 장기 그룹은 구획이라고 하는 작은 영역으로 구성됩니다. 근막이라고 하는 조직의 보호 벽은 구획의 보호 벽을 형성합니다. 특정 부상 후 혈액이 구획에 축적될 수 있습니다. 근막의 단단한 벽은 쉽게 확장될 수 없으므로 구획 압력이 증가하여 구획 내부의 조직으로 충분한 혈류가 흐르지 않습니다. 조직이 완전히 손상되면 신체 기능을 상실하거나 사망에 이를 수 있습니다. 구획 증후군이 발생하기 쉬운 신체 기관은 다리, 팔, 복부입니다. 구획 증후군의 5P는 구획 증후군과 관련된 증상인 통증, 창백(창백한 피부), 이상감각 (무감각), 맥박 없음(낮은 맥박 ), 마비(약함)입니다.

급성 구획 증후군은 다리나 팔이 부러져서 생기는 흔한 구획 증후군입니다. 급성 증후군은 압궤 부상, 꽤 꽉 감은 붕대, 화상, 팔 혈관의 혈전으로 인해 발생합니다.

The chronic compartment syndrome develops over weeks. It is caused by regular exercise. The compartment syndrome can be treated by reducing the excess pressure in the body compartment. The substances which are hindering the affected body part such as wound dressings, casts, splints should be removed. Supportive treatment is also used to cure the compartment syndrome. In order to cure abdominal compartment syndrome, life support machines such as dialysis and blood pressure vasopressors are used.

The increased incidence of compartment syndrome caused due to burns and chronic ailments, rise in geriatric population, rise in ongoing research and development, availability of opiods and non-steroidal anti-inflammatory drugs (NSAIDS) and rise in disposable income for Compartment Syndrome Treatment are predicted to drive the market growth. In males the incidence of acute compartment syndrome is predicted to be around 7.3 per 100,000 and in females it is 0.7 per 100,000. However, the lack of health remuneration policies, rise in cost, side effects associated with the use of NSAIDS and risks associated with the surgery are expected to hinder the market growth. The rise of emerging markets in developing countries, rise of untapped opportunities, upcoming healthcare clinics, advent of novel therapies for  reducing the pressure of the compartment are the opportunities which are projected to bolster the market growth. The dearth of expertise, rise in drugs recalls, use of alternatives other than NSAIDs, and are the challenges which can tamper the market growth.

This Compartment Syndrome Treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Compartment Syndrome Treatment Market Scope and Market Size

The compartment syndrome treatment market is segmented on the basis of type, drug type, application, treatment type, route of administration, mode of purchase and distribution channel. The growth among segments helps you analyses niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the compartment syndrome treatment market is segmented into acute, chronic.
• On the basis of drug type, the compartment syndrome treatment market is segmented into opiods, non opiods, non steroidal anti-inflammatory drugs (NSAIDS).
• On the basis of application, the compartment syndrome treatment market is segmented into head trauma and cardiology.
• On the basis of treatment type, the compartment syndrome treatment market is segmented into surgery, supportive treatment, anti-inflammatory medications, physiotherapy.
• On the basis of route of administration, the compartment syndrome treatment market is segmented into oral, parenteral, intravenous.
• On the basis of mode of purchase, the compartment syndrome treatment market is segmented into prescription and over the counter.
• On the basis of distribution channel, the compartment syndrome treatment market has also been segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.

Compartment Syndrome Treatment Market Country Level Analysis

Compartment syndrome treatment market is analysed and market size information is provided by country, type, drug type, application, treatment type, route of administration, mode of purchase and distribution channel as referenced above.

The countries covered in the compartment syndrome treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America is expected to hold the largest market share due to the rise in capita expenses of the patient population on health and presence of well-trained healthcare providers. Asia Pacific is also expected to account for the second largest market share due to the rise in point of care diagnostics, rise of upcoming wound closure devices and untapped opportunities in emerging markets.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

구획 증후군 치료 시장은 또한 환자 분석, 예후 및 치료에 대한 자세한 시장 분석을 제공합니다. 유병률, 발생률, 사망률, 준수율은 보고서에서 사용할 수 있는 일부 데이터 변수입니다. 시장 성장에 대한 역학의 직접 또는 간접 영향 분석을 분석하여 성장 기간 동안 시장을 예측하기 위한 보다 견고하고 코호트 다변량 통계 모델을 만듭니다.

경쟁 환경 및 구획 증후군 치료 시장 점유율 분석

구획 증후군 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 구획 증후군 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

구획 증후군 치료 시장에서 다루는 주요 기업으로는 Novartis AG, Pfizer Inc, Johnson & Johnson Services, Inc, Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Torrent Pharmaceuticals Ltd., Bayer AG, Lupin Pharmaceuticals, Inc., Stryker, CJ Medical, Cardinal Health., Wound Care Technologies, Inc. MediGroup EBI, 3M 등이 있으며, 국내 및 글로벌 기업도 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-60444